XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Nonvested Restricted Stock Shares Activity
The following table contains summarized information about restricted stock issued during the years ended December 31, 2024 and the nine months ended September 30, 2025:
Restricted StockCommon SharesWeighted Average
Grant Date
Fair Value
Weighted Average
Remaining Years
to Vest
Nonvested at December 31, 2023— $— 0.0
Granted125,863 2.54 
Vested(125,863)2.54 
Nonvested at December 31, 2024— $— 0.0
Granted102,342 2.64 
Vested(102,342)2.64 
Nonvested at September 30, 2025— $— 0.0
Schedule of Nonvested Restricted Stock Units Activity
The following table contains summarized information about restricted stock units during the year ended December 31, 2024, and the nine months ended September 30, 2025:
Restricted Stock UnitsCommon SharesWeighted Average
Grant Date
Fair Value
Weighted Average
Remaining Years
to Vest
Nonvested at December 31, 2023962,849 $2.60 2.5
Granted(1)
2,348,423 2.31 
Vested(956,679)2.54 
Forfeited(305,821)2.41 
Nonvested at December 31, 20242,048,772 $2.33 2.6
Granted768,967 2.80 
Vested(448,793)2.31 
Forfeited(213,489)2.55 
Nonvested at September 30, 20252,155,457 $2.48 2.8
(1)    In the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, the table summarizing the number of shares granted during the year inadvertently omitted certain equity awards, although the correct total was disclosed in the accompanying narrative. The total number of shares granted during 2024 was 2,348,423, inclusive of awards to both executive and non-executive employees. The previously reported table total of 1,858,023 has been updated to reflect the correct number of granted shares. This did not have an impact on our financial statements for the period.
Schedule of Share-based Payment Arrangement, Option, Activity
A summary of option activity under the 2011 Equity Incentive Plan during the year ended December 31, 2024, and the nine months ended September 30, 2025, is presented below:
Options OutstandingCommon SharesWeighted Average
Exercise Price
Weighted Average
Remaining Life
(Years)
Outstanding at December 31, 2023343,601 $9.53 5.2
Exercised(65,154)1.21 
Expired(244,588)10.51 
Forfeited(520)9.24 
Outstanding at December 31, 202433,339 $18.60 3.7
Exercised(125)2.08 
Expired(10,778)28.40 
Forfeited(9)12.61 
Outstanding at September 30, 202522,427 $13.98 4.3
Exercisable at September 30, 202522,426 $13.98 4.3
Schedule of Nonvested Share Activity
A summary of the nonvested stock option activity under the 2011 Equity Incentive Plan during the years ended December 31, 2024, and the nine months ended September 30, 2025, is presented below:
Nonvested OptionsCommon SharesWeighted Average
Grant Date
Fair Value
Weighted Average
Remaining Years
to Vest
Nonvested at December 31, 202326,373 $8.83 1.1
Vested(24,728)18.60 
Forfeited(520)9.24 
Nonvested at December 31, 20241,125 18.60 3.7
Vested(1,115)13.98 
Forfeited(9)12.61 
Nonvested at September 30, 2025$13.98 0.1
Schedule of Share-Based Payment Arrangement, Performance Shares, Outstanding Activity
The following table contains summarized information about inducement grant-related RSUs during the year ended December 31, 2024, and the nine months ended September 30, 2025.
Inducement SharesTime-BasedPerformance BasedTotal
Grant Outstanding at December 31, 202310,000 328,354 338,354 
Granted219,355 — 219,355 
Forfeited (1)
(179,355)(328,354)(507,709)
Grant Outstanding at December 31, 202450,000 — 50,000 
Granted— — — 
Forfeited— — — 
Grant Outstanding at September 30, 2025
50,000 — 50,000 
(1)    Inducement shares forfeited in 2024 were related to the divestiture of Hoozu in December, 2024.
Schedule of Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award Total stock-based compensation expense recognized on restricted stock, restricted stock units, stock options, and employee stock purchase plan issuances during the three and nine months ended September 30, 2025 and 2024 was recorded in the Company’s consolidated statements of operations as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Cost of revenue$114,587 $82,608 $178,376 $191,053 
Sales and marketing90,085 50,567 139,809 171,774 
General and administrative240,971 1,446,061 768,304 1,965,529 
Total stock-based compensation$445,643 $1,579,236 $1,086,489 $2,328,356 
Schedule of Accumulated Other Comprehensive Income (Loss) The activity in accumulated other comprehensive income (loss) for the three and nine months ended September 30, 2025, and 2024, respectively, was as follows:
Three Months Ended
September 30, 2025September 30, 2024
Unrealized Gain (Loss) on SecuritiesCurrency Translation AdjustmentReclassification of Foreign Currency Translation Adjustment to IncomeTotal Accumulated Other Comprehensive Income (Loss)Unrealized Gain (Loss) on SecuritiesCurrency Translation AdjustmentTotal Accumulated Other Comprehensive Income
Balance at June 30$— $(17,095)$(34,218)$(51,313)$(99,784)$(12,302)$(112,086)
Other comprehensive income (loss)— 1,048 — $1,048 84,855 (94,195)$(9,340)
Balance at September 30$— $(16,047)$(34,218)$(50,265)$(14,929)$(106,497)$(121,426)
Nine Months Ended
September 30, 2025September 30, 2024
Unrealized Gain (Loss) on SecuritiesCurrency Translation AdjustmentReclassification of Foreign Currency Translation Adjustment to IncomeTotal Accumulated Other Comprehensive Income (Loss)Unrealized Gain (Loss) on SecuritiesCurrency Translation AdjustmentTotal Accumulated Other Comprehensive Income
Balance at December 31$12,209 $127,296 $(34,218)$105,287 $(250,591)$— $(250,591)
Other comprehensive income (loss)(12,209)(143,343)— (155,552)235,662 (106,497)129,165 
Balance at September 30$— $(16,047)$(34,218)$(50,265)$(14,929)$(106,497)$(121,426)